Talya Miron-Shatz, PhD.


Talya Miron-Shatz is a decision scientist specializing in medical decision making. Her research examines people’s understanding of health information, and ways of improving it. An important focus of her work is on adherence to medication, and developing scientifically valid interventions for improving adherence through behavioral means. Her work is published in peer-reviewed journals and in books (MIT, Oxford University Press).

She has a PhD from the Hebrew University in social and experimental psychology, and spent five years at Princeton University, as post-doctoral fellowship at Princeton University with Nobel Laureate Daniel Kahneman. From 2008 - 2011 she taught consumer behavior at Wharton, University of Pennsylvania, with an emphasis on health consumerism. In addition to being a senior fellow at CMPI, Talya is an associate professor at the Ono Academic College, where she is founding director of the Center for Medical Decision Making. Dr. Miron-Shatz is CEO of CureMyWay, a start-up company developing personalized adherence solutions.
 
Her invaluable academic and industry experience makes her a sought after public speaker on behavior change. 
 
Her Psychology Today blog deals with issues such as 'does diet soda make you thin?'  and 'what do tattoos have to do with hemophilia?'
Sign Up for Our Email Newsletter

RECENT NEWS

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients
  • CMPI
  • 09/09/2022 12:00 AM

New Report Demonstrates How Hospitals, Pharmacies & PBMs Exploit the Federal 340B Drug Program to the Harm of Disadvantaged Patients

Nation’s largest hospitals, pharmacy benefit managers (PBMs), and pharmacies abuse drug discount program to pocket saving...  Read more

Peter Pitts on CDC reorganization proposal

Peter Pitts on CDC reorganization proposal

Peter Pitts joins NEWSY to discuss proposed CDC changes...  Read more

Why the FTC is Investigating Pharmacy Benefit Managers

Why the FTC is Investigating Pharmacy Benefit Managers

In money matters, U.S. regulators are investigating claims by PBMs who say they save you money on prescriptions....  Read more

DRUGWONKS BLOG